医学
阶段(地层学)
穿孔
结直肠癌
化疗
内科学
淋巴结
优势比
外科
癌症
胃肠病学
生物
古生物学
冶金
材料科学
冲孔
作者
Miren Orive,Ane Antón,Nerea González,Urko Aguirre,Rocío Anula,Santiago Lázaro,Maximino Redondo,Marisa Baré,Eduardo Briones,Antonio Escobar,Cristina Sarasqueta,J. Ferreiro,José M. Quintana
摘要
Objective To identify factors associated with early, intermediate or late recurrence colon cancer recurrence. Methods A total of 1,732 consecutive patients with colon cancer were recruited and followed for a period of 5 years. Recurrence at 1 year (early), from 1 to 2 (early), from 2 to 3 (intermediate) and from 3 to 5 years (late) was the main outcome measures. Results Predictors of early recurrence (AUC (95% CI):0.74 (0.70–0.78) were as follows: TNM stage II and III, more than one type of invasion, haemoglobin <10 g/dl, residual tumour (R1), ASA IV, log odds of positive lymph nodes ratio ≥−0.53, perforation, neoadjuvant chemotherapy, infectious complications within 1 year and CEA pre- and post-intervention. These factors remained significant for predicting intermediate (AUC [95% CI]: 0.72 [0.67–0.77]) and late (AUC [95% CI]: 0.68 [0.63–0.74]) recurrence, except for ASA class, log lymph node ratio, perforation and neoadjuvant chemotherapy. Additionally, laterality (left) and medical complications up to 2 years were significant. Conclusions These risk factors show good predictive ability of early, intermediate and late recurrence, confirming factors established by guidelines and adding some others. They could serve to provide more appropriate and accurate treatment and follow-up tailored to patient characteristics.
科研通智能强力驱动
Strongly Powered by AbleSci AI